Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. Glazkova
Observed name:
E. A. Glazkova
Institution:
Moscow Multidisciplinary Clinical Center "Kommunarka"
Observed institutions:
Russian Cancer Research Center NN Blokhin,
Moscow Multidisciplinary Clinical Center "Kommunarka"
ORCID:
0000-0003-4141-2274
Observed ORCID:
0000-0003-4141-2274
OpenAlex ID:
A5035881650
97P Comparison of the efficacy of regorafenib, reintroduction and rechallenge of chemotherapy (CT) with anti-EGFR in the third-line treatment of metastatic colorectal cancer (mCRC) with wild-type RAS and BRAF of left-sided localization: Results of a multicenter retrospective study
2026
·
E. Kuzmina
, M.Y. Fedyanin
, et al.
·
Annals of Oncology
PDF
Pro-arrhythmogenic effect of lappaconitine hydrobromide
2026
·
S. S. Yakushin
, N. V. Yenenkov
, et al.
·
Clinical Medicine (Russian Journal)
126P Efficacy and safety of trastuzumab deruxtecan (T-DXd) in HER2-positive (HER2+) advanced breast cancer (ABC) with CNS progression after local treatment: Real-world data
2025
·
M. Sukhova
, L. Zhukova
, et al.
·
Annals of Oncology
460eP Real-world outcomes of patients with advanced hepatocellular carcinoma: A retrospective cohort study
2025
·
A. Rays
, E. Kotova
, et al.
·
Annals of Oncology
238eP Comparison of the efficacy of regorafenib and reintroduction of chemotherapy (CT) with anti-EGFR in the 3rd-line treatment of metastatic colorectal cancer (mCRC) with wild-type RAS and BRAF of left-sided localization - results of a retrospective study
2025
·
E. Kuzmina
, P. Feoktistova
, et al.
·
Annals of Oncology
1083P Platinum-based vs non-platinum chemotherapy in platinum-resistant relapsed ovarian cancer (PROC): A randomized phase II trial
2025
·
A. Rumyantsev
, I. Pokataev
, et al.
·
Annals of Oncology
426P Safety of Sputnik V COVID-19 vaccine in cancer patients receiving chemotherapy: An observational study
2022
·
A. Rumyantsev
, E. Glazkova
, et al.
·
Annals of Oncology
541P Efficacy of various anticancer agents after failure of maintenance olaparib: A retrospective study
2022
·
A. Rumyantsev
, A. Tyulyandina
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
8
Citation count:
H-index:
I10-index:
Year
Topic
Type